Study of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Nippon Kayaku Co.,Ltd.

ClinicalTrials.gov Identifier:

NCT01238952

First received: November 2, 2010

Last updated: March 18, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2013
Primary Completion Date:	November 2010 (Final data collection date for primary outcome measure)